Mitsubishi Ufj Trust & Banking Corp Repligen Corp Transaction History

Mitsubishi Ufj Trust & Banking Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$120.0 - $182.95 $188,400 - $287,231	-1,570 Reduced 5.94%	24,874 $3.14 Million
Q1 2024 May 10, 2024	SELL	$170.78 - $208.42 $294,595 - $359,524	-1,725 Reduced 6.12%	26,444 $4.86 Million
Q4 2023 Feb 09, 2024	SELL	$114.17 - $185.35 $145,224 - $235,765	-1,272 Reduced 4.32%	28,169 $5.06 Million
Q3 2023 Nov 09, 2023	SELL	$138.78 - $176.51 $234,121 - $297,772	-1,687 Reduced 5.42%	29,441 $4.68 Million
Q2 2023 Aug 08, 2023	BUY	$138.42 - $180.31 $28,376 - $36,963	205 Added 0.66%	31,128 $4.4 Million
Q1 2023 May 10, 2023	BUY	$154.26 - $198.1 $143,307 - $184,034	929 Added 3.1%	30,923 $5.21 Million
Q4 2022 Feb 10, 2023	BUY	$162.42 - $220.56 $4.87 Million - $6.62 Million	29,994 New	29,994 $5.08 Million

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.94B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.